Eric Fabbrizio

1.6k total citations
33 papers, 1.2k citations indexed

About

Eric Fabbrizio is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Eric Fabbrizio has authored 33 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Cell Biology. Recurrent topics in Eric Fabbrizio's work include Muscle Physiology and Disorders (12 papers), Epigenetics and DNA Methylation (10 papers) and Cancer-related gene regulation (9 papers). Eric Fabbrizio is often cited by papers focused on Muscle Physiology and Disorders (12 papers), Epigenetics and DNA Methylation (10 papers) and Cancer-related gene regulation (9 papers). Eric Fabbrizio collaborates with scholars based in France, United States and Israel. Eric Fabbrizio's co-authors include Claude Sardet, Dominique Mornet, Selma El Messaoudi, Jolanta Polanowska, Laurent Le Cam, Conception Paul, Charles Theillet, Matthieu Lacroix, Geneviève Rodier and Vincent Nègre and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Medicine.

In The Last Decade

Eric Fabbrizio

33 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Fabbrizio France 17 1.1k 144 105 97 81 33 1.2k
R Wisdom United States 9 692 0.6× 248 1.7× 76 0.7× 70 0.7× 42 0.5× 9 993
Marie-Pierre Leibovitch France 17 598 0.6× 92 0.6× 108 1.0× 112 1.2× 63 0.8× 34 731
Sophie Currier United States 7 682 0.6× 34 0.2× 122 1.2× 156 1.6× 94 1.2× 7 811
Tae Ho Shin United States 13 1.2k 1.1× 122 0.8× 340 3.2× 97 1.0× 60 0.7× 13 1.4k
Eliška Krejčí Czechia 13 392 0.4× 111 0.8× 85 0.8× 76 0.8× 15 0.2× 24 651
Cheryl L. Neudauer United States 10 743 0.7× 94 0.7× 462 4.4× 54 0.6× 137 1.7× 11 1.0k
Allison S. Cleary United States 7 423 0.4× 160 1.1× 123 1.2× 74 0.8× 187 2.3× 14 711
Cyril Esnault France 11 658 0.6× 90 0.6× 159 1.5× 44 0.5× 83 1.0× 16 910
P. Daubas France 9 689 0.6× 53 0.4× 103 1.0× 120 1.2× 39 0.5× 18 873
Ulrich Putz Australia 17 1.1k 1.0× 83 0.6× 73 0.7× 63 0.6× 56 0.7× 21 1.4k

Countries citing papers authored by Eric Fabbrizio

Since Specialization
Citations

This map shows the geographic impact of Eric Fabbrizio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Fabbrizio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Fabbrizio more than expected).

Fields of papers citing papers by Eric Fabbrizio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Fabbrizio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Fabbrizio. The network helps show where Eric Fabbrizio may publish in the future.

Co-authorship network of co-authors of Eric Fabbrizio

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Fabbrizio. A scholar is included among the top collaborators of Eric Fabbrizio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Fabbrizio. Eric Fabbrizio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saksouk, Nehmé, Marine Pratlong, Célia Barrachina, et al.. (2020). The mouse HP1 proteins are essential for preventing liver tumorigenesis. Oncogene. 39(13). 2676–2691. 16 indexed citations
2.
Paul, C., Claude Sardet, & Eric Fabbrizio. (2011). The histone- and PRMT5-associated protein COPR5 is required for myogenic differentiation. Cell Death and Differentiation. 19(5). 900–908. 20 indexed citations
3.
Lacroix, Matthieu, et al.. (2008). The histone‐binding protein COPR5 is required for nuclear functions of the protein arginine methyltransferase PRMT5. EMBO Reports. 9(5). 452–458. 109 indexed citations
4.
Schmidt, Susanne, Sylvie Diriong, Jean Méry, Eric Fabbrizio, & Anne Debant. (2002). Identification of the first Rho–GEF inhibitor, TRIPα, which targets the RhoA‐specific GEF domain of Trio. FEBS Letters. 523(1-3). 35–42. 54 indexed citations
5.
Fabbrizio, Eric, Selma El Messaoudi, Jolanta Polanowska, et al.. (2002). Negative regulation of transcription by the type II arginine methyltransferase PRMT5. EMBO Reports. 3(7). 641–645. 185 indexed citations
6.
Polanowska, Jolanta, Eric Fabbrizio, Laurent Le Cam, et al.. (2001). The periodic down regulation of Cyclin E gene expression from exit of mitosis to end of G1 is controlled by a deacetylase- and E2F-associated bipartite repressor element. Oncogene. 20(31). 4115–4127. 24 indexed citations
7.
Fajas, Lluís, Laurent Le Cam, Jolanta Polanowska, et al.. (2000). A CDE/CHR‐like element mediates repression of transcription of the mouse RB2 (p130) gene. FEBS Letters. 471(1). 29–33. 28 indexed citations
8.
Fabbrizio, Eric, Laurent Le Cam, Jolanta Polanowska, et al.. (1999). Inhibition of mammalian cell proliferation by genetically selected peptide aptamers that functionally antagonize E2F activity. Oncogene. 18(30). 4357–4363. 69 indexed citations
9.
Lu, Xianping, Andrea Fanjul, Nathalie Picard, et al.. (1997). Novel retinoid-related molecules as apoptosis inducers and effectve inhibitors of human lung cancer cells in vivo. Nature Medicine. 3(6). 686–690. 71 indexed citations
10.
Fabbrizio, Eric, et al.. (1995). Dystrophin, the Protein That Promotes Membrane Resistance. Biochemical and Biophysical Research Communications. 213(1). 295–301. 16 indexed citations
11.
Lees, Delphine M., Eric Fabbrizio, Dominique Mornet, D. Pugnère, & Pierre Travo. (1995). Parallel Expression Level of Dystrophin and Contractile Performances of Rat Aortic Smooth Muscle. Experimental Cell Research. 218(1). 401–404. 14 indexed citations
12.
Fabbrizio, Eric, et al.. (1995). Re-evaluation of the distributions of dystrophin and utrophin in sciatic nerve. Biochemical Journal. 312(1). 309–314. 27 indexed citations
13.
Lees, Delphine M., et al.. (1994). Dystrophin (Xp21), a New Phenotype Marker of Cultured Rat Aortic Myocytes. Experimental Cell Research. 210(2). 230–235. 10 indexed citations
14.
Fabbrizio, Eric, et al.. (1994). N‐terminal domain of dystrophin. FEBS Letters. 355(1). 49–53. 19 indexed citations
15.
Fabbrizio, Eric, Uri Nudel, Gérald Hugon, et al.. (1994). Characterization and localization of a 77 kDa protein related to the dystrophin gene family. Biochemical Journal. 299(2). 359–365. 50 indexed citations
16.
Fabbrizio, Eric, Jocelyne Léger, Jean Léger, & Dominique Mornet. (1993). Dystrophin and dystrophin-related protein expression in Torpedo marmorata electric organ. Neuroscience Letters. 155(1). 51–56. 9 indexed citations
17.
Fabbrizio, Eric, et al.. (1993). Actin-dystrophin interface. Biochemistry. 32(39). 10457–10463. 65 indexed citations
18.
Fabbrizio, Eric, Jocelyne Léger, Monique Anoal, Jean Léger, & Dominique Mornet. (1993). Monoclonal antibodies targeted against the C‐terminal domain of dystrophin or utrophin. FEBS Letters. 322(1). 10–14. 29 indexed citations
19.
Fabbrizio, Eric, et al.. (1992). Properties of chicken cardiac dystrophin. Biology of the Cell. 76(2). 167–174. 6 indexed citations
20.
Caubit, Xavier, et al.. (1992). Patterns of dystrophin expression in developing, adult and regenerating tail skeletal muscle of Amphibian urodeles.. PubMed. 36(4). 555–65. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R Wisdom Breakdown of academic impact, for papers by Marie-Pierre Leibovitch Breakdown of academic impact, for papers by Sophie Currier Breakdown of academic impact, for papers by Tae Ho Shin Breakdown of academic impact, for papers by Eliška Krejčí Breakdown of academic impact, for papers by Cheryl L. Neudauer Breakdown of academic impact, for papers by Allison S. Cleary Breakdown of academic impact, for papers by Cyril Esnault Breakdown of academic impact, for papers by P. Daubas Breakdown of academic impact, for papers by Ulrich Putz
Rankless by CCL
2026